A comparative analysis showed that the percentage of inflammatory cells expressing CXCL10 in skin lesions from AOSD patients was significantly greater than that in normal controls (p = 0.012) and patients with eczema (p = 0.019) or psoriasis (p = 0.009). This evidence concerns the gene CXCL10 and psoriasis.